SALT LAKE CITY, February 2, 2025 – Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to participate in the following upcoming investor conferences.
- BTIG at Snowbird: The 12th Annual MedTech, Digital Health, LS&D Tools Conference in Salt Lake City, UT – Wednesday, February 12, 2025 (1×1 meetings only)
- Riley Securities Precision Oncology & Radiopharma Conference – Friday, February 28, 2025 in New York, NY (1×1 meetings only)
About Varex
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,300 people located in North America, Europe, and Asia. For more information visit vareximaging.com.
# # #
For Information Contact:
Christopher Belfiore
Director of Investor Relations
Varex Imaging Corporation
801.973.1566 | investors@vareximaging.com
Articles
VAREX TO PARTICIPATE IN CJS SECURITIES 25TH ANNUAL NEW IDEAS FOR THE NEW YEAR VIRTUAL CONFERENCE
Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the CJS Securities 25th Annual New Ideas for the New Year Virtual Conference.
VAREX ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER FISCAL YEAR 2024
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2024.
VAREX SCHEDULES THIRD QUARTER FISCAL YEAR 2024 EARNINGS RELEASE AND CONFERENCE CALL
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2024 following the close of regular trading on Thursday, August 1, 2024.
VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2024
Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024.
VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION
Varex Imaging Corporation (Nasdaq: VREX) today announced it has entered into a senior secured revolving credit agreement (the “RLOC Facility”) for an initial aggregate principal amount of up to $155 million.
VAREX TO PRESENT AT OPPENHEIMER 34TH ANNUAL HEALTHCARE MEDTECH & SERVICES VIRTUAL CONFERENCE
Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference.